A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)
Clinical trial NCT06660563 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06660563
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-22
- Primary completion
- 2026-01-19
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.